by admin | Sep 12, 2022 | News and Opinions
Moderna is suing Pfizer and BioNTech, alleging they copied technology that Moderna first developed years before the pandemic in producing the first COVID-19 vaccine approved in the U.S., the company announced Friday. Driving the news: Moderna is seeking unspecified...
by admin | Sep 11, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Sarah Collins and Jacqueline Garget – University of Cambridge Researchers from the University of Cambridge have created model embryos from mouse stem cells that form a brain, a beating heart, and the foundations of all the other organs of the body – a new...
by admin | Sep 11, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Michael Irving – New Atlas Joint pain is a common ailment of aging, thanks to cartilage’s tendency to wear out. Now, researchers at Duke University have developed a new hydrogel that’s stronger and more durable than the real thing, which could make for longer...
by admin | Aug 2, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Dr. Atala leads an interdisciplinary team that has developed 15 clinically used tissue applications and is working on more than 40 tissues and organs Newswise — CHICAGO (June 10, 2022): Anthony Atala, MD, FACS, Winston-Salem, North Carolina, will be presented with the...
by admin | Jul 26, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Max Bayer – Fierce Pharma Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday...
